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Summary
We identiﬁed a Leishmania major-speciﬁc gene that
can partly compensate for the loss of virulence
observed for L. major HSP100 null mutants. The gene,
encoding a 46 kD protein of unknown function and
lineage, also enhances the virulence of wild type L.
major upon overexpression. Surprisingly, the
approximately sixfold overexpression of this protein
also extends the host range of L. major to normally
resistant C57BL/6 mice, causing persisting lesions in
this strain, even while eliciting a strong cellular
immune response. This enhanced virulence in vivo is
mirrored in vitro by increased parasite burden inside
bone marrow-derived macrophages. The localization
of the protein in the macrophage cytoplasm suggests
that it may modulate the macrophage effector
mechanisms. In summary, our data show that even
minor changes of gene expression in L. major may
alter the outcome of an infection, regardless of the
host’s genetic predisposition.
Introduction
Leishmania major is the causative agent of zoonotic, cuta-
neous leishmaniasis. Like all leishmaniae, these parasites
appear in two morphologically distinct life cycle stages.
The ﬂagellated, cigar-shaped promastigote proliferates in
the digestive tract of the vectors, phlebotomine sandﬂies,
and infects mammals, including humans. Inside the mam-
malian host, the parasites develop into the non-ﬂagellated
amastigote stage that persists and proliferates inside
various immune cells, such as monocytes, tissue
macrophages, but also dendritic cells (Bogdan and Roll-
inghoff, 1999). The inﬁltration of immune effector cells into
the infected tissue causes ulcerating, but usually self-
healing skin lesions in humans.
Among the leishmaniae, L. major is the chosen model
for experimental infections. The mouse infection models
of L. major have given researchers a wealth of information
over the last two decades, not only about this particular
host-parasite interaction, but also about the general
response of the mammalian immune system to invading
pathogens. In particular, the striking differences observed
between the course of L. major infections in different
mouse strains (Handman et al., 1979) have helped to
establish the antagonistic effects of cellular and humoral
immune responses (Lohoff et al., 1998; Bogdan and Roll-
inghoff, 1999).
Typically,infectionofC57BL/6micewithL.majorcauses
minor, transient swellings at the inoculation site that heal
spontaneously within 2–3 weeks. This course of infection
was correlated with an early TH1 type, cellular immune
response, characterized by the production of speciﬁc
cytokines, such as interleukin (IL)-12 and g-interferon
(IFNg). By contrast, a cutaneous infection of BALB/c mice
with L. major leads to a progressive, ulcerating skin lesion
andheavyparasiteloadinthelocallymphaticsystem.This
is correlated with a TH2-driven, humoral immune response
and characterized by increased IL-4 levels (Bogdan et al.,
1996;BogdanandRollinghoff,1998).Fromtheseﬁndings,
it was deduced that the genetic predisposition of the host
animal largely determines the outcome of L. major experi-
mental infections.
However, the genetic makeup of the parasite also has a
strong impact on infectivity and virulence. Patient isolates
of L. infantum were found to comprise a variety of clonal
lines with varying virulence and tropism (Garin et al.,
2001). Even the TH1/TH2 dichotomy of the early immune
response may be inﬂuenced strongly by clonal variations
of the infecting parasite (Reiling et al., 2006).
The factors governing inherent virulence of the parasite
are less known. Reverse genetic analyses showed that
the replacement of certain genes may impair intracellular
parasite viability or parasite infectivity (Mottram et al.,
1996; Hubel et al., 1997; Zhang and Matlashewski, 1997;
Wiese, 1998). However, reverse genetics cannot identify
unknown virulence markers as only likely candidate
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The gene encoding HSP100 was established as viru-
lence factor by a reverse genetic approach (Hubel et al.,
1997; Krobitsch and Clos, 1999). It is expressed almost
exclusively in the amastigote stage (Krobitsch et al.,
1998; Rosenzweig et al., 2008). Consequently, L. major
hsp100-/- gene replacement mutants which lack this gene
were found to be avirulent in BALB/c mice and non-
infectious to isolated macrophages while showing only
minor effects in the promastigote stage. Further work both
with L. major and L. donovani established a stringent
requirement for HSP100 inside the host cells, but not in
any axenic culture stages including in vitro generated
amastigotes of L. donovani (Krobitsch and Clos, 1999).
Recently, we found that spontaneous clonal divergence
within an L. major hsp100-/- population lead to the emer-
gence of parasites with recovered virulence (Reiling et al.,
2006). The molecular basis for this spontaneous gain of
virulence is unknown. We therefore decided to use the L.
major hsp100-/- mutant in a functional cloning screen to
identify genes and proteins that can restore virulence to
this attenuated mutant. The use of functional cloning, or
complementation genetics, is well established in Leish-
mania spp. and facilitates the unbiased search for genes
for selectable traits, such as drug resistance (Choudhury
et al., 2008), but also lipophosphoglycan synthesis (Ryan
et al., 1993b; Descoteaux et al., 1995; 2002) and viru-
lence (Beverley and Turco, 1998; Zhang and Matlash-
ewski, 2004).
Here, we describe the identiﬁcation and characteriza-
tion of a virulence gene, encoding a 46 kD protein that
restores infectivity to L. major hsp100-/-, boosts wild type
L. major virulence and widens the host range while also
increasing the parasite burden in macrophages.
Results
Preparation of a cosmid library from L. major hsp100-/-
In order to identify genes that compensate the loss of
virulence of the L. major hsp100-/-, we chose a clone, not
previously described, in which the HSP100 alleles are
replaced by hygromycin phosphotransferase and puromy-
cin acetyltransferase genes. This clone allows for the
G418 selection of cells transfected with the cosmid vector
pcosTL and its derivatives. To exclude the HSP100 gene
from the screen, we prepared a cosmid library from the
genomic DNA of the null-mutant and generated a recom-
binant population of L. major hsp100-/- [pcoslibrary].
Functional cloning
To select for recombinant parasites with restored viru-
lence, the L. major hsp100-/- [pcoslibrary] population was
subjected to selection by passage in BALB/c mice. L.
major wild type and the parent null-mutant were used as
controls. Figure 1A shows the course of the experimental
infections. Wild type L. major caused rapid footpad swell-
ing, starting at 2 weeks post infection, while no footpad
swelling could be observed with the null-mutant, conﬁrm-
ing its attenuated phenotype. Null-mutants carrying the
cosmid library DNA showed an intermediate virulence.
Lesions appeared 8 weeks post infection. Obviously,
some of the cosmids restored virulence to the hsp100-/-
mutant.
To recover the virulence promoting cosmids, the mice
infected with the recombinant parasite population were
sacriﬁced. Promastigotes were grown from lesion and
lymph node tissue. Cosmid DNA from the selected popu-
lations was then isolated and cloned in Escherichia coli.
Fifty clones each of bacteria transformed with skin- or
Fig. 1. In vivo screening.
A. Lesion formation in Balb/c mice. A total of 3 ¥ 10
7 stationary phase promastigotes of L. major wild type (solid squares), L. major hsp100
-/-
transfected with pcosTL vector (open triangles) or L. major hsp100
-/- [pcoslibrary] (open diamonds) were inoculated subcutaneously into the
hind footpads of female Balb/c mice. Footpad swelling for each group (n = 4) was monitored at weekly intervals. The error bars indicate the
SEM. †: time point of euthanasia.
B. Characterization of selected cosmids by restriction fragment length analysis. Cosmids were cut with EcoRV and XbaI, and the DNA
fragments were separated by ﬁeld inversion gel electrophoresis (FIGE). Identical fragment length patterns are marked by brackets. The arrow
marks the pcosTL backbone. Preﬁx a: in vivo selected cosmids; preﬁx p: in vitro selected cosmids; M: marker lane.
C. Results of the secondary in vivo screen. L. major was transfected with the cosmids isolated in the primary screen (B). A representative mix
of these recombinants was used for BALB/c mouse infections. Parasites were recovered from footpad lesions (white bars) and draining lymph
nodes (grey bars). Distribution of the different cosmids in the selected parasites was determined by subcloning in E. coli (100 clones each)
and clonal restriction fragment analysis (not shown). For each cosmid prototype its relative abundance (in %) is shown. Numbers on top of the
bars: number of animals (out of ﬁve) from which each cosmid was recovered.
D. Open reading frames (ORFs) of the cosmid pcosA13 with accession numbers, putative function, size and predicted molecular mass
(MM ¥ 1000).
E. Schematic representation of pcosA13 derivatives. Cosmids pcosA13-BglI2 and pcosA13-Xba2 were constructed by digestion of pcosA13
with BglII and XbaI, respectively, and subsequent re-ligation. Cosmids pcosA13.3 and pcosA13.4 were isolated by DNA hybridization from the
plated cosmid library and characterized by terminal sequencing. Shaded boxes symbolize intact ORFs; open boxes show incomplete ORFs.
Grey lines represent vector DNA. ORF 4 is highlighted by inverse print.
F. Frequencies of 4 pcosA13 derivatives recovered from three tissues taken from two infected animals: mouse #1 foot (#1, FT) and draining
lymph node (#1, LN), and mouse #2 lymph node (#2, LN).
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restriction fragment length analysis, using XbaI and
EcoRV digestion followed by agarose gel electrophoresis
(not shown). We identiﬁed 22 cosmid prototypes, named
pcosA1 to pcosA22, of which seven dominated the selec-
tion and were entered into a secondary screening.
In parallel, two L. major hsp100-/- [pcoslibrary] popula-
tions were cultivated in liquid medium for 26 days. This
was done to select for and exclude cosmids that confer an
in vitro growth advantage. The cosmid DNA was isolated
and cloned in E. coli. A total of 100 clones were also
analysed by XbaI/EcoRV restriction fragment length
analysis (not shown). Nine cosmid prototypes were found,
named pcosP1 to pcosP9, ﬁve of which were abundant
and added to the secondary screen.
We performed ﬁeld inversion gel electrophoresis to
compare the restriction fragment length patterns of the
preselected cosmids. Two of the cosmids selected in the
amastigote stage showed patterns indistinguishable from
cosmids that had been favoured in the promastigote
stage, namely pcosA1/pcosP3 and pcosA2/pcosP1
(Fig. 1B). We suspected that these cosmids were not
favoured in the mouse but during the subsequent in vitro
cultivation.
All preselected cosmids were subjected to partial
sequence analysis of their genomic DNAinserts. By align-
ing the obtained sequences with the L. major Genome
Project database, we determined which genomic regions
were represented. Contrary to our expectations, none of
the selected cosmids contain genes that code for molecu-
lar chaperone proteins, e.g. HSP70, HSP40 or HSP90
(Table 1). This indicates that HSP100 is a unique chaper-
one protein in Leishmania which cannot be substituted by
other heat shock proteins.
To determine which of the cosmids provided the stron-
gest effect on parasite survival in mice, we transfected
each preselected cosmid individually into L. major
hsp100-/-. The individual transfectants were mixed at
equal ratios and used to infect BALB/c mice (n = 5).Again,
wild type L. major and L. major hsp100-/- were used as
controls. Footpad swelling was monitored weekly (not
shown). As predicted, the mixed hsp100-/- population
transfected with the preselected cosmids showed an
intermediate virulence (not shown), conﬁrming the results
of the ﬁrst selection.
Parasites were recovered and grown in vitro from skin
lesion tissue and draining lymph nodes. Cultivation of L.
major from the lymph node of mouse #4 failed due to
bacterial contamination. Cosmids from the remaining
parasite cultures were cloned, subjected to XbaI and
EcoRV digestion and analysed by agarose gel electro-
phoresis (images not shown). The prevalence of the
various cosmid types was then determined for each
source (ﬁve mice, two tissues each). Figure 1C shows the
results. The pcosA13 was the most prominent cosmid in
the secondary selection. It was recovered from four out of
ﬁve mice. In addition, it was not selected in the promas-
tigote culture, suggesting a speciﬁc effect inside the host.
Cosmid pcosA20 also showed high prevalence, but was
recovered only from three out of ﬁve mice. It, too, was only
favoured during the mouse passage. Cosmid pcosA2/P1
was recovered from three mice, but it was also favoured in
the promastigote and thus excluded from further analysis.
The remainder of the cosmids showed lower overall
Table 1. Cosmids selected in the screen.
Cosmid Gene I.D. Description
pcosA13 LmjF33.3030 hypothetical protein, conserved
LmjF33.3040 ABC transporter family-like protein
LmjF33.3050 Tyrosyl-DNA phosphodiesterase
LmjF33.3060 hypothetical protein, conserved
LmjF33.3070 Concanavalin A-like lectin/glucanase (430 of 7552 aa)
pcosA20 LmjF24.1420 lectin/glucanase
LmjF24.1430 kinesin, putative
LmjF24.1435 conserved hypothetical protein
LmjF24.1440 conserved hypothetical protein
LmjF24.1450 protein kinase, putative
LmjF24.1460 conserved hypothetical protein
LmjF24.1470 conserved hypothetical protein (693 of 2428aa)
pcosA2/P1 LmjF05.0710 CYC2-like cyclin, putative
LmjF05.0720 phophatase-like protein
LmjF05.0730 hypothetical protein, conserved
LmjF05.0740 hypothetical protein, conserved
LmjF05.0750 hypothetical protein, conserved
LmjF05.0760 kinesin-like protein
LmjF05.0770 hypothetical protein, unknown function
The putative proteins encoded by the three dominant cosmids: pcosA13, pcosA20 and pcosA2/P1. Data taken from the TritrypDB
(http://tritrypdb.org/tritrypdb/).
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that pcosA13 contains gene(s) that overcome the attenu-
ated phenotype of L. major hsp100-/- in mice.
Characterization of pcosA13
The insert of pcosA13 represents sequences from L.
major chromosome 33, between positions 1 470 145 and
1 508 412. They comprise four complete and one partial
open reading frames (Fig. 1D). LmjF33.3030 (ORF-1)
encodes a hypothetical protein of 115 kD. The 156 kD
product of LmjF33.3040 (ORF-2) is annotated as an ABC
transporter protein, while LmjF33.3050 (ORF-3) codes for
a putative tyrosyl DNA phosphodiesterase. The last intact
open reading frame, LmjF33.3060 (ORF-4), is listed as
encoding a 46 kD protein of unknown function. The ﬁfth,
incomplete ORF, LmjF33.3070, is part of the coding
sequence for a hypothetical, conserved 821 kD
polypeptide.
To determine which of the ﬁve coding sequences are
responsible for the restored virulence, derivatives and
variants of pcosA13 were generated either by truncation
(pcosA13.1 and pcosA13.2) or by selection from the
cosmid library (pcosA13.3 and pcosA13.4). These were
used for a third round of selection and are shown sche-
matically in Fig. 1E.
Leishmania major hsp100-/- was transfected with
cosmids pcosA13.1-4. The transgenic populations were
mixed at equal ratio and used to infect BALB/c mice. As
before, we observed lesion formation with the wild type
controls and with the recombinant parasite inoculates, but
not with the parent hsp100-/- mutant (not shown). Parasites
wereisolatedfromtheinfectedmice,andthedistributionof
pcosA13 derivatives was determined (Fig. 1F). Two
cosmids, pcosA13.3 and pcosA13.1, were recovered from
the surviving parasites. Only ORF 4 is common to both
constructs. Conversely, cosmids pcosA13.4 and
pcosA13.2 were not recovered. Both cosmids lack
the ORF 4. Therefore, the third selection implicates
LmjF33.3060 (ORF 4) as responsible for the restored
virulence.
Analysis of ORF 4 (LmjF33.3060)
The LmjF33.3060 gene encodes a 46 kD protein. Using
recombinantly expressed 46 kD protein (P46), we immu-
nized mice and obtained antisera which recognize the
antigen faithfully in a Western blot (Fig. 2A). We also
performed a native gradient gel electrophoresis to assess
thenativesizeofP46(Fig. 2B).Whilenaivemouseserado
not detact bands in the blot, the anti-P46 antisera decorate
aproteinbandcorrespondingtoanativemolecularmassof
~300 000, possibly representing a hexameric complex.
We performed extensive database mining to identify
putative functional domains and motifs within P46 and to
identify related genes/proteins. The amino acid sequence
does not contain known functional motifs or localization
signals. A search for homologues turned up only one
Fig. 2. Characterization of ORF 4.
A. Western blot of recombinantly expressed 46 kD protein probed with anti-P46 antiserum. Marker bands are annotated; arrow indicates the
recognized 46 kD protein band.
B. Native gradient gel electrophoresis and Western blot. Promastigotes of L. major (lanes 1, 3) or L. major [pcosP46] (lanes 2, 4) were lysed
under non-denaturing conditions, and the lysates were separated by pore gradient gel electrophoresis. Following Western transfer, the
membranes were probed either with naive mouse serum (lanes 1, 2) or with anti-P46 serum (Lanes 3, 4). The marker lane (M) blot was
stained with Coomassie Brilliant Blue. Marker protein positions are indicated to the left. The arrow points at the major P46-speciﬁc band.
C. Protein-DNA matrix plot (Pustell, Mac Vector™ Suite) of L. major P46 amino acid sequence against the corresponding region of the L.
infantum genome (CHR 33, position 1 371 444–1 372 905). The blue arrows show the relative extent of the open reading frames; plot
parameters are given in the top right corner. Extent of the L. infantum open reading frame relative to the L. major sequence in indicated
(dotted lines).
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tum. A protein to DNA matrix plot (Fig. 2C) shows conser-
vation between the L. major protein and the cognate L.
infantum genomic region. However, the L. infantum
sequence contains only a small open reading frame rep-
resenting less than 40% of the L. major amino acid
sequence. A similarly incomplete conservation was found
when we compared P46 with the preliminary sequence
(www.sanger.ac.uk/sequencing/Leishmania/mexicana/)
from the corresponding region of L. mexicana chromo-
some 32 (not shown). No open reading frame was found in
thecorrespondinggenomicregionofL.braziliensis.There-
fore, P46 appears to be unique to L. major.
Overexpression of P46 enhances virulence
in BALB/c mice
To verify P46 as the virulence enhancing gene product,
we constructed an episome that contains only
LmjF33.3060 plus its 5′- and 3′ untranslated ﬂanking
regions. The resulting cosmid, pcosP46, and the vector,
pcosTL, were both transfected into L. major and into L.
major hsp100-/-, to test the effect of P46 overexpression in
both genetic backgrounds. The recombinant strains were
grown in liquid medium and their proliferation rates were
indistinguishable from wild type L. major (data not shown).
The P46 overexpressing parasites were tested in the
mouse infection model. As expected, overexpression of
P46 in L. major hsp100-/- restored virulence to the mutant.
Detectable lesions appeared 7 weeks post infection
(Fig. 3A), while the parent null-mutant did not cause
lesions within the observation span, except for one animal
where a lesion developed at 9 weeks. This conﬁrms that
P46 is indeed responsible for the partial reversal of the
hsp100-/- phenotype.
Overexpression of P46 also had signiﬁcant effects on
wild type L. major virulence. While both L. major and L.
major [pcosP46] induced lesions within 3 weeks, the
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Fig. 3. P46 Overexpressing Parasites in the Mouse Infection Model.
A. L. major hsp100-/- (solid triangles) or L. major hsp100-/- [pcosP46] (open triangles) were inoculated into footpads of BALB/c mice (n = 5).
Footpad swelling [mm] was monitored at weekly intervals.
B. Infection of BALB/c mice (n = 4) with L. major (solid squares) or L. major [pcosP46] (open squares). Footpad swelling was monitored
weekly.
C. Real-time RT-PCR. The relative P46-speciﬁc mRNA levels in log phase promastigotes of L. major hsp100
-/-, L. major hsp100
-/- [pcosp46], L.
major wild type and L. major [pcosP46] were determined by whole cell RNA extraction, cDNA synthesis and subsequent P46-speciﬁc real-time
PCR. Results are given as multiples of L. major wild type expression levels.
D. C57BL/6 mice (n = 4) were infected with either L. major (solid squares) or L. major [pcosP46] (open squares). Footpad swelling was
monitored over 110 days.
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Even at these extreme lesion sizes, we did not observe a
tendency towards ulceration, indicating an impact of P46
on the interaction of the parasite with the host immune
system.
This result shows that the P46 overexpression is not a
functional complementation for the lacking HSP100.
Rather, P46 enhances virulence and thus compensates
for the attenuated phenotype. Although unexpected, the
strong effect of P46 overexpression on the virulence of
wild type L. major was deemed sufficiently important and
worthwhile of further investigation.
We ascertained P46 overexpression by real-time
RT-PCR of RNA isolated from logarithmic growth phase
promastigotes, using actin mRNA as internal standard.
P46 expression in wild type L. major is elevated by a
factor of 6 due to the pcosP46 transgene, compared with
a 24-fold overabundance in the hsp100-/- mutants carrying
the cosmid (Fig. 3C). Of note is that the recombinant
parasites had already undergone one mouse passage at
the point of the analysis. Therefore, in the hsp100-/-
mutant, the selective pressure on P46 overexpression
was probably higher, due to the low inherent virulence of
this mutant.
P46 overexpression boosts L. major virulence in
C57BL/6 mice
The observations in the BALB/c mouse model led us to
test the effects of P46 overexpression in the C57BL/6
mouse model. In these mice, L. major-induced lesions are
minor and transient. Indeed, we observed a minor swell-
ing at 5 weeks post infection with L. major wild type
(Fig. 3D, solid squares). By contrast, L. major [pcosP46]
causes prominent and lasting lesions in C57BL/6 mice
(Fig. 3D, open squares). The observed footpad swelling
correlates with increased persistence and/or proliferation
of the P46 overexpressing parasites which we could
detect by histological staining and microscopy (data not
shown). Nevertheless, the infection was controlled at a
moderate lesion size and towards the end of the obser-
vation time the footpad swelling began to recede. Obvi-
ously, C57BL/6 mice are ultimately able to control the
infection. Therefore, P46 overexpressing parasites can
temporarily overcome or outgrow the protective immune
response in the early stages of infection in C57BL/6 mice.
P46 does not suppress the TH1 immune response of
C57BL/6 mice
Resistance to L. major infection is normally correlated with
an early induction of the TH1 arm of the immune response.
A hallmark of the TH1 type response is the enhanced
production of IFNg and the repression of IL-4 synthesis.
Faced with the persistance of P46 overexpressing L.
major in C57BL/6 mice, we tested cytokine production in
draining lymph nodes 17 days post infection, using IL-4
and IFNg sandwich ELISA. First, we recovered a threefold
higher number of cells from the lymph nodes of mice
infected with L. major [pcosP46], compared with control
infections (Fig. 4A). Thus, infection with P46 overexpress-
ing L. major causes an increased inﬂux of cells into the
draining lymph nodes. We did not observe IFNg produc-
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Fig. 4. Cytokine response in C57BL/6 mice. C57BL/6 mice were
infected with L. major or L. major [pcosP46]. At day 17
post-infection draining lymph nodes were isolated. Lymph node
cells were counted (A) and triplet samples of 3 ¥ 10
5 cells each
were stimulated with anti-CD3 or L. major soluble antigen. After
72 h, the supernatants were collected and analysed by sandwich
ELISA for either IFNg (B) or IL-4 (C). The data are the results of
one experiment with 10 mice per group. Values are given as
means ( SEM). Asterisk: P < 0.05.
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By contrast, L. major [pcosP46] induced strong IFNg pro-
duction either with L. major lysate or with anti-CD3 anti-
body (Fig. 4B). IL-4 production was weakly induced by
anti-CD3 challenge, but not using Leishmania lysate, with
L. major [pcosP46] infection causing a slightly stronger
response (Fig. 4C). These results demonstrate that
C57BL/6 mice still mount a strong, potentially protective
TH1 type immune response against the P46 overexpress-
ing L. major. Therefore, the persistence and proliferation
of L. major [pcosP46] does not suppress the predominant
TH1 immune response typical for C57BL/6 mice.
We also performed equivalent experiments in BALB/c
mice which typically mount an IL-4-driven TH2 immune
response after L. major infection. Here, we observed no
signiﬁcant differences in cytokine production between
mice infected with wild type or P46 overexpressing para-
sites (data not shown). Hence, the cytokine expression
pattern in mice does not change in response to P46
overexpression in L. major. This result hints at an impact
of P46 on host defence mechanisms downstream of T
helper cell activation.
Localization of P46 in L. major promastigotes
The surface molecules of L. major have been shown to
impact on the infectivity of the parasites. To test for the
possibility that P46 might also be found on the surface of L.
major,weﬁrstdetermineditslocalizationinpromastigotes,
using immune ﬂuorescence microscopy. The antibody
decorates the cytoplasm, including the ﬂagellum, and
sparing both nucleus and kinetoplast (Fig. 5E–H).There is
no evidence for a surface localization. Identical results
were obtained with a second batch of antiserum from a
different animal (not shown). No ﬂuorescence is obtained
using secondary antibodies alone (Fig. 5A–D) or in con-
junction with pre-immune mouse serum (not shown).
To conﬁrm this cytoplasmic localization, we also per-
formed immune electron microscopy. While naive mouse
sera fail to decorate the promastigote microsections
(Fig. 5I), the P46 antiserum recognizes distinct foci in the
cytoplasm of the parasites (Fig. 5K). The clustered
appearance hints at the formation of multimeric com-
plexes and supports the results from the native electro-
phoresis (Fig. 2B). We conclude that P46 is a cytoplasmic
protein in promastigotes, localizing to distinct foci.
Localization of P46 within the infected macrophage
Because P46 exerts its virulence enhancing effects during
the mammalian stage of the parasite’s life cycle, we next
analysed the distribution of P46 in amastigotes within
infected macrophages. To this end, bone marrow-derived
macrophages were infected with either wild type L. major
or with L. major [pcosP46]. After 24 h, infected cells were
ﬁxed and stained with anti-P46 serum and DAPI. No anti-
P46 staining is observed in uninfected macrophages
(data not shown). Figure 6A–D shows the result for the
infection with L. major wild type. The DAPI stain marks the
macrophage nucleus (mn), but also the parasite nucleus
(n) and kinetoplast (k). The anti-P46 staining is found in
distinct foci within the macrophage cytoplasm and does
not match the localization of the parasites. This is even
more pronounced in macrophages infected with the
L. major [pcosP46] (Fig. 6E–H). The P46 foci in these
macrophages are larger and found within clusters,
often in small areas that are free of parasites.
A co-staining, using anti-lamp1 sera to highlight endo-
somes, showed no signiﬁcant colocalization with the anti-
P46 staining (data not shown), arguing against a tight
association with the parasitophorous vacuoles. To clarify
this, we performed an immune electron microscopy of
L. major [pcosP46]-infected bone marrow-derived
macrophages. Again, naive mouse sera do not stain the
infected macrophage or the intracellular parasites
(Fig. 7A). By contrast, the anti-P46 antibodies decorate
focal assemblies of antigen both inside the parasite and in
the cytoplasm of the infected macrophage (Fig. 7B). This
result conﬁrms that P46 is exported to the macrophage
and shows that the protein is not associated with the
endosome compartment. The presence of P46
inside the parasites was not detected by indirect
immunoﬂuorescence. This may be due to inefficient diffu-
sion of antibody through host cell cytoplasmic membrane,
parasitophorous vacuole membrane and parasite cyto-
plasmic membrane, but it may also be owed to the supe-
rior resolution of immune EM.
P46 boosts infectivity in vitro
The indirect immune ﬂuorescence images in Fig. 6 also
suggested a greater parasite load for macrophages
infected with L. major [pcosP46]. This prompted us to
determine infection rates and parasite loads after in vitro
infection. For this, we performed a series of ﬁve infection
experiments with L. major wild type and L. major
[pcosP46] in bone marrow-derived macrophages. For
each experiment, 100–200 macrophages were viewed.
Infection rates and parasite loads were quantiﬁed by ﬂuo-
rescence microscopy after DAPI staining. Infection rates
of macrophages increased signiﬁcantly (P = 0.01) from
33% to 59.8% due to P46 overexpression (Fig. 8A). Also,
average parasite loads (Fig. 8B) deﬁned as amastigotes
per infected macrophage increased almost twofold
(10.7–17.5). This difference is highly signiﬁcant (P <
0.0001). Both effects add up to threefold increase of para-
site burden in the cultured macrophages. We conclude
that P46 overexpression confers a substantial advantage
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and conﬁrming the in vivo infection data.
Discussion
Genetic complementation is a tried strategy in Leishmania
spp. and has been used to identify a variety of genes
responsible for a diverse set of traits (Ryan et al.,
1993a,b; Turco et al., 1994; Beverley and Turco, 1995;
Descoteaux et al., 2002; Coelho et al., 2003; Choudhury
et al., 2008). Episomes are maintained stably in L. major,
and even in the absence of antibiotic selection, such
transgenes can persist for multiple generations in the
animal host (Hubel et al., 1997; Hoyer et al., 2004). The
foremost advantage of functional cloning is the potential
to select genes according to their function, regardless of
preconceptions. The unbiased nature of complementation
genetics makes it likely to identify heretofore uncharacter-
ized genes and proteins and implicate them in cellular
functions and structures.
A
B
C
D
E
F
G
H
I
K
\
 k
\
 k \
 n
 n
/
 /
n
5μ m 5μ m
\
 n
Fig. 5. P46 localization in promastigotes. (A–H) Indirect immunoﬂuorescence. L. major promastigotes were probed without primary antibody
as controls (A–D) or with anti-P46 antiserum (E–H). Phase contrast (A,E); DAPI staining of nucleus and kinetoplast (B,F). Immune detection
without (C) or with (G) anti-P46 serum. D and H show overlays of immune detection and DAPI stain (I–K). Immunogold (10 nm) electron
microscopy of L. major [pcosP46] promastigotes using naive mouse serum (I) or anti-P46 serum (K). n = nucleus. 500 nm size bar at the
bottom.
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we have screened a genomic DNA library for genes that
may reverse that attenuation, i.e. restore parasite
virulence. Indeed, we were able to isolate a small number
of cosmids that fulﬁlled this criterion. It is telling that none
of the selected cosmids harbours any of the leishmanial
heat shock genes. In the yeast model Saccharomyces
cerevisiae, the loss of the HSP100 orthologue, HSP104,
can be complemented in part by overexpression of
HSP70 (Sanchez et al., 1993). There are several
members of the HSP70 gene family in the L. major
genome, but none of these genes were selected to com-
pensate for the lack of HSP100. This underscores that
induction of thermotolerance, one of the best character-
ized functions of yeast HSP104, may not be the key role
for Leishmania HSP100 (Krobitsch and Clos, 1999).
Some of the selected cosmids were also favoured in in
vitro promastigote culture and therefore excluded from
consideration. Of the remaining three candidates, one
dominated the in vivo selections and was further
analysed. The virulence enhancing property could be
attributed to a single gene, LmjF33.3060, which encodes
a 46 kD protein of unknown function and phylogenetic
lineage.
Overexpression of this protein, dubbed P46, reliably
restored virulence to the hsp100-/- null-mutant. Surpris-
ingly, the effect of P46 overexpression is not conﬁned to
the null-mutant, but is also observed in a wild type genetic
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Fig. 6. P46 localization in infected macrophages. Bone marrow-derived macrophages were infected with L. major (A–D) or L. major
[pcosP46] (E–H) at a 1:10 cell ratio and stained with anti-P46 antiserum and DAPI. Bright ﬁeld images (A,E), DAPI stain (B,F) and anti-P46
stain (C,G) are shown. (D,H): DAPI and anti-P46 overlays. mn = macrophage nucleus; k = kinetoplast; n = parasite nucleus. 10 mm size bars
are shown.
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does not functionally complement the null-mutant but
rather compensates for the attenuated phenotype. Thus,
the approach did not further our knowledge of HSP100
function in L. major. In spite of this, P46 is worthwhile of
attention.
There is no structural similarity to other proteins in the
database, and even sequence conservation with L. infan-
tum is comparatively weak. No open reading frame was
found in the corresponding genomic region of L.
braziliensis. There is no evidence of divergence for this
gene within the L. major species, though. L. major Friedlin
strain (Genome Project) and L. major 5ASKH (our study)
were isolated from different geographical areas, Israel
and Turkmenistan respectively (Al-Jawabreh et al., 2008).
Yet, we ﬁnd no sequence divergence between P46 genes
of the two strains (data not shown). Therefore, P46
appears to be speciﬁc to L. major and may even serve as
a molecular marker to distinguish Old World Leishmania
species. This requires further analyses of various cutano-
tropic Old World leishmaniae.
It has been shown before that spontaneous genetic
rearrangements can revert the phenotype of genetically
attenuated L. major (Spath et al., 2004; Reiling et al.,
2006). Also in the L. major model, it could be shown that
two established laboratory strains, L. major Friedlin and
L. major MHOM/IL/81/FEBNI, both of Middle Eastern
origin, display different infection courses in mice deﬁ-
cient in TNF production (Ritter et al., 2004), indicating
that TNF-dependent control of L. major infection is
dependent on the parasite strain. Similarly, earlier work
nuc
Fig. 7. Immune electron microscopy of infected macrophages.
Bone marrow-derived macrophages were infected with L. major
[pcosP46] at a 1:10 cell ratio. After 24 h, infected cells were
suspended and subjected to immunogold (10 nm) electron
microscopy, using naive mouse serum (A) or anti-P46 serum (B).
Arrow heads delineate the parasitophorous vacuole membranes,
500 nm size bars are shown at the bottom. kin = kinetoplast,
ﬂg = ﬂagellum, nuc = nucleus.
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Fig. 8. In vitro macrophage infection experiments. Bone
marrow-derived macrophages were infected with L. major or
L. major [pcosP46] at a 1:10 cell ratio. Macrophages (100–200 per
sample) were analysed for parasite infection. The infection rate
as percentage of infected macrophages, and the parasite load as
number of parasites per infected macrophage were determined by
ﬂuorescence microscopy.
A. Scatter plot of infection rates (n = 5). Signiﬁcance was tested by
paired t-test; P (two-tailed) = 0.001.
B. Scatter plot of parasite loads (n = 600). P (two-tailed) = 5.9 E-06,
U-test.
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within an infecting population of L. infantum displayed
different virulence and tissue tropism. Thus, spontane-
ous clonal variations may inﬂuence the outcome of an
infection, compounding issues such as the host’s immu-
nological predisposition.
However, the molecular bases for these events remain
unknown. Here, we describe for the ﬁrst time that the
relatively minor overexpression of a single gene can
restore virulence and even alter the host range. The ﬁve-
fold P46 overexpression in L. major exacerbates the
pathology in BALB/c mice and allows productive and
lasting infection of normally resistant C57BL/6 mice. Con-
trary to our expectation, this is not brought about by a
reversal of the TH1/TH2 dichotomy in the C57BL/6 mice.
Rather, the persisting infection with L. major [pcosP46]
causes an increased IFNg release. The fact that the over-
expressing L. major can survive in the face of a strong
IFNg response indicates that P46 protects against effector
mechanisms downstream of a macrophage activation.
Similar results were obtained earlier with spontaneous
escape variants of L. major hsp100-/- (Reiling et al., 2006).
As L. major has the ability to induce or prevent the expres-
sion of distinct host genes (Racoosin and Beverley, 1997),
it should be interesting to perform an RNA microarray
analysis of L. major-infected macrophages with and
without P46 overexpression. The results may shed light
on immune modulatory mechanisms of Leishmania spp.
This idea is supported by the results of the in vitro
infections. Elevated P46 levels corresponded with
elevated infectivity and parasite loads. Both effects
combine to a tripled overall parasite load in the macroph-
age culture. Preliminary results show that this is not due to
more efficient uptake by the macrophage, but rather
through improved intracellular survival and/or proliferation
(M.C., unpubl. obs.). These in vitro observations match
and explain the results obtained in the mouse model. The
strongly increased parasite numbers in the macrophage
population most likely cause expansion of the infected
cells and also a stronger inﬂux of immune cells, explaining
both the increased tissue swelling and the increased IFNg
stimulation.
How does P46 enhance intracellular survival/
proliferation? So far, repeated attempts to generate P46
null mutants by homologous recombination failed. Neither
single allele nor double allele gene replacement mutants
could be raised under antibiotic selection. There are two
explanations for this: (i) the expression of selection
marker genes as directed by P46 untranslated ﬂanking
regions is too low for sufficient antibiotic resistance, or (ii)
the expression of P46 is essential for efficient parasite
growth. Our inability to even generate single allele
replacements argues in favour of the former explanation.
We have therefore halted these efforts.
In promastigotes, P46 shows a cytoplasmic distribution
which probably changes due to stage conversion. This
requires either stage speciﬁc processing or amastigote-
speciﬁc export pathways. There are no conserved signal
sequences in P46. However, recent work (Silverman
et al., 2008) suggests that Leishmania utilizes non-
classical secretion pathways dispensing with the need for
signal sequences.
Indeed, new research results conﬁrm exosomal trans-
port as a means for protein export from Leishmania para-
sites to their environment (Silverman et al., 2010). The
payload of these exosomes comprises most chaperones,
including HSP100. Additional research using L. major
should clarify whether P46 is a part of the proteins
exported via exosomal pathways.
The lack of an in vitro stage conversion system so far
precludes a kinetic study of P46 trafficking during
differentiation. This is compounded by the fact that, for
reasons still unknown, a P46::eGFP chimeric protein was
expressed poorly in infected macrophages (data not
shown). Different labelling of P46 for life imaging or the
development of an axenic amastigote model for L. major
are required to address this question.
Clearly, more information is needed about the role and
function of this protein. The phylogenetic distribution of
P46 among cutanotropic Old World leishmaniae and its
relative levels of expression in various L. major isolates
should be researched, to establish possible correlations
with geographical or clinical parameters. New attempts to
generate P46 null mutants must be started, using varia-
tions of standard protocols. Lastly, macrophage gene
expression should be analysed to detect the impact of
P46 overexpression on leishmanicidal or immune modu-
latory mechanisms.
Experimental procedures
Parasite culture
Promastigote L. major (MHOM/SU/73/5ASKH) were grown at
25°C in modiﬁed Medium199 (Sigma-Aldrich, with 20% heat
inactivated FCS, 40 mM HEPES pH 7.4, 0.2% NaHCO3,
100 mM adenin, 1.2 mgm l
-1 6-biopterin, 10 mgm l
-1 haem,
20 mgm l
-1 gentamicin, 2 mM L-glutamin, pH 7.0). For mac-
rophage and mouse infection experiments, parasites were
allowed to grow to stationary phase. Promastigotes were
counted using a CASY cell counter (Roche).
Generating L. major hsp100-/- (Puror/Hygror)
The L. major hsp100
-/- mutant was created by replacing the
HSP100 coding sequence with neoR and hygR marker genes
(Hubel et al., 1997). The cosmid vector pcosTL confers neo-
mycin (G418) resistance and is not compatible with G418
resistant host strains. Therefore, in order to use a pcosTL-
based library in the hsp100
-/- mutants, we had to replace the
1186 L. Reiling, M. Chrobak, C. Schmetz and J. Clos 
© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 76, 1175–1190neomycin resistance marker from the null mutants. For this
purpose, the plasmid pL.m.clpB hygro (Hubel et al., 1997)
was cleaved using KpnI and BamHI, deleting the hygromycin
resistance marker. Then, the puromycin resistance gene
(PAC) was inserted in the same place, resulting in the
plasmid pL.m.clpB puro. XbaI digest of this pL.m.clpB puro
plasmid resulted in a fragment encomapssing the HSP100
untranslated regions ﬂanking the PAC gene. This fragment
was used to transfect L. major hsp100
-/- (Neo
r/Hygro
r), to
target the neomycin phosphotransferase gene in the HSP100
gene locus for replacement. Clonal selection under puromy-
cin and hygromycin selected for parasites that had replaced
the neomycin phosphotransferase gene against the PAC
gene. A clone (TF3.1) resistant to puromycin but not neomy-
cin was veriﬁed by PCR analysis and chosen for transfection
with the cosmid library.
Preparation and screening of cosmid library
The cosmid library was generated as described previously
(Choudhury et al., 2008), with the exception that genomic
DNA of a L. major HSP100 null mutant was used. To prepare
cosmids for transfection of L. major, cosmids were
puriﬁed from E. coli by alkaline lysis, phenol/chloroform/
isoamylalcohol extraction and subsequent isopropanol
precipitation. Hybridization screening of the cosmid library
was performed following established protocols (Sambrook
et al., 1989) and using digoxigenin-labelled DNA probes.
Transfection
The transfection procedure was performed as described
(Choudhury et al., 2008). Brieﬂy, parasites from logarithmic
growth phase were washed twice in pre-chilled PBS (pH 7.0),
once in pre-chilled electroporation buffer (21 mM HEPES pH
7.5, 137 mM NaCl, 5 mM KCl, 0.7 mM Na2HPO4,6 m M
Glucose) and resuspended in electroporation buffer to a ﬁnal
concentration of 1 ¥ 10
8 ml
-1. An equivalent of 4 ¥ 10
7 para-
sites was mixed with 2 mg of DNA for homologous recombi-
nation, or 50 mg of DNAfor stable episomal transfection. Cells
were transferred to an electroporation cuvette (0.4 cm gap,
Biozym) and pulsed three times using a Gene Pulser™ (Bio-
Rad) at 3000 V cm
-1 for homologous recombination, or
3750 V cm
-1 for episomal transfection (25 mF, 200 W). Follow-
ing electroporation, parasites were transferred to fresh, modi-
ﬁed Medium199 and grown for 24 h without selection before
puromycin (45 mgm l
-1), hygromycin (50 mgm l
-1) and/or G418
(neomycin) (50 mgm l
-1) were added.
Experimental infections
Three days prior to infection, parasites were grown in modi-
ﬁed Medium199 until stationary phase was reached. Para-
sites were washed twice and resuspended in pre-chilled
phosphate buffered saline pH 7.0 (PBS). Parasite suspen-
sion (1–4 ¥ 10
7 in 50 ml of PBS) was inoculated s.c. into the
rear foot pads of BALB/c or C57BL/6 mice. Footpad size was
monitored weekly. Mice were sacriﬁced before lesions
ulcerated. For parasite reisolation, the lesion tissues and the
draining lymph nodes were prepared, homogenized and sus-
pended in modiﬁed Medium199 and the appropriate antibiotic
pressure was applied. The medium was also supplemented
with penicillin/streptomycin (100¥ PenStrep, Sigma) to avoid
bacterial contamination. For cytokine quantiﬁcation experi-
ments, mice were sacriﬁced 17 days post infection.
Isolation and cloning of cosmid DNA from Leishmania
Isolation and cloning of cosmid DNA from Leishmania pro-
mastigotes was performed as described (Choudhury et al.,
2008).
Truncated variants of pcosA13
Both ends of the cosmid insert were ampliﬁed enzymatically
using speciﬁc primers. The ampliﬁcation products were
labelled with digoxigenin-dUTP and used to screen colony
lifts on cellulose nitrate ﬁlters by hybridization. Two out of 10
cosmid clones were identiﬁed as sufficiently different from
pcosA13 by terminal sequencing of the inserts (pcosA13.3;
pcosA13.4). The truncated variants pcosA13.1 and
pcosA13.2 were obtained by digestion with BglII or XbaI
respectively. Digestion of pcosA13 with BglII and subsequent
re-ligation of the truncated cosmid deleted ORF-3 and the 3′
half of ORF-2. Digestion of pcosA13 with XbaI and subse-
quent ligation deleted ORF-3, ORF-4, and the incomplete
ORF-5, as well as 60% of ORF-2. For expression of ORF 4
alone, a ~5400 nt segment of pcosA13 was ampliﬁed, span-
ning the entire 5′- and 3′-non-coding regions, and including
LmjF33.3060. The primers used added XbaI sites to the
ampliﬁcation product, which was then ligated into XbaI-
digested pcosTL vector (Kelly et al., 1994). The resulting
cosmid, pcosP46, contains LmjF33.3060 with its natural
ﬂanking sequences.
In vitro infection experiments
Murine bone marrow macrophages (BMM) were isolated
from the femurs of female C57BL/6 mice and differentiated in
Iscove’s Modiﬁed Dulbecco’s Medium (IMDM) supplemented
with 10% heat inactivated FCS, 5% horse serum and 30%
L929 supernatant (modiﬁed after Racoosin and Swanson,
1989). For infection, BMM were harvested, washed and
seeded into the wells of an eight-well chamber slide (NUNC)
at a density of 4 ¥ 10
5 cells per well. The macrophages were
incubated for 48 h at 37°C and 9% CO2 to allow adhesion of
the cells. Adherent BMM were infected with stationary phase
promastigotes (Racoosin and Beverley, 1997) at a multiplicity
of infection of 10 parasites per macrophage. After 4 h of
incubation at 37°C in modiﬁed Medium199, non-
phagocytosed parasites were removed by multiple washing
steps with PBS and incubation was continued for another
24 h in IMDM at 37°C and 9% CO2. The medium superna-
tants was removed. The cells were washed twice and ﬁxed in
ice-cold methanol. Intracellular parasites were quantiﬁed by
nuclear staining with DAPI (1.25 mgm l
-1, Sigma) and ﬂuores-
cence microscopy.
Field inversion gel electrophoresis (FIGE)
1% agarose gels were prepared and run in fresh 0.5¥ TBE
buffer using the following multi-phase program: Program 1:
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Mode reverse; F/R ratio 3:1. Program 2: 200V; run time 8 h;
pulse time 0.8–1.5 s; Mode reverse; F/R ratio 3:1. After the
run, gels were stained in ethidium bromide (10 mgm l
-1 in 0.5¥
TBE buffer).
Analysis of cytokine production
Draining lymph nodes and spleens from infected C57BL/6
or BALB/c mice were isolated 17 days post infection. After
determining organ weight and cell numbers, single-cell sus-
pensions were seeded in triplicate into 96-well plates
(3 ¥ 10
5 cells per well), using RPMI medium supplemented
with 10% heat-inactivated fetal-calf serum, L-glutamine
(2 mM) and Pen/Strep (1¥, Sigma). Cells were stimulated
with either 6 mgm l
-1 anti-CD3 mab or L. major lysate. After
72 h, supernatants were collected and preserved at -20°C.
Production of interferon-g (IFNg) and IL-4 was assessed
in a speciﬁc two-sided ELISA using supernatant of
stimulated lymph node cells. Antibody pairs and cytokine
standards were purchased from R&D Systems GmbH
(Wiesbaden).
Antibodies
The coding region for P46 was ampliﬁed and expressed in E.
coli using the expression vector pJC45 as described
(Schlueter et al., 2000). The His-tagged protein was puriﬁed
from bacterial lysates by nickel affinity chromatography. The
recombinant protein was used together with Freund’s com-
plete adjuvant to immunize NMRI mice, followed by two
boosts with incomplete adjuvant. Heparanised blood from
immunized animals was collected by cardiac puncture after
CO2 euthanasia. Serum was obtained after centrifugation and
tested by Western blotting. Anti-mouse IgG alkaline phos-
phatase was purchased from Dianova, Alexa Fluor 594 goat
anti-mouse IgG from Invitrogen.
SDS-PAGE and Western blotting
Production of SDS cell lysates, discontinous SDS-PAGE
and Western blot were performed according to standard
protocols, using FluoroTrans PVDF membranes (Pall).
Membranes were blocked (5% milk powder in Tris-buffered
saline, 0.1% Tween 20), probed with the polyclonal antise-
rum (1:250 in blocking solution) before incubation
with an anti-mouse IgG-alkaline phosphatase conjugate
(1:2500, Dianova). Blots were developed using nitro blue
tetrazolium chloride and 5-bromo-4-chloro-3-indolyl phos-
phate (Sigma).
Pore gradient gel electrophoresis
Extraction of non-denatured Leishmania proteins and native
gradient gel electrophoresis was performed largely according
to Westwood et al. (1991). Promastigotes (1 ¥ 10
7) were har-
vested by centrifugation, washed twice with PBS and resus-
pended in 40 ml of extraction buffer (15% glycerol, 0.5 mM
1,10-phenanthroline, 10 mM Tris-HCl pH 8,0, 70 mM KCl).
After four freeze and thaw cycles, cell lysates were cleared by
centrifugation. The supernatant, containing the soluble
protein fraction, was mixed (5:1, v/v) with loading buffer (50%
glycerol, 0,1% bromphenol blue). The samples were run
alongside a high molecular weight protein marker for native
gels (Amersham) on a 4–18% polyacrylamide (2.5–6% glyc-
erol) gradient gel in 0.5 ¥ TBE buffer. Electrophoresis was
allowed to proceed for 24 h at 4°C, at 20 V cm
-1. This long
duration of electrophoresis was necessary for all proteins to
migrate to their exclusion limit regardless of their net charge
(Andersson et al., 1972). After that, the gel was incubated at
60°C in transfer buffer (48 mM Tris, 39 mM glycine, 0.5%
SDS, 10 mM DTT) for 30 min, followed by Western blot
analysis.
Immunoﬂuorescence and confocal microscopy
For immunoﬂuorescence labelling, log-phase promastigotes
(1 ¥ 10
7 cells) were washed twice and resuspended in PBS.
Cells (2 ¥ 10
5) were immobilized on poly (L-lysine) coated
microscopic slides and ﬁxed for 10 min in acetone. Non-
adherent cells were removed by a gentle wash (0.1% Triton
X-100 in PBS). Slides with ﬁxed parasites or infected mac-
rophages were then incubated for 15 min at RT with perme-
abilization buffer (50 mM NH4Cl and 0.1% Triton X-100 in
PBS), followed by a 15 min incubation in blocking solution
(2% BSA and 0.1% Triton X-100 in PBS). Cells were washed
thrice and incubated sequentially with: (i) dilutions of primary
antibody (1:500), (ii) ﬂuorescent secondary antibody
(1:2500), (iii) with DAPI (1.25 mgm l
-1, Sigma). After washing
(3¥), Mowiol (CalBiochem) and coverslips were applied. Fluo-
rescence images were captured using an Olympus FluoView
FV1000 confocal microscope and the Olympus Fluoview Ver.
1.7b software.
Immune electron microscopy was performed following
established protocols (Krobitsch et al., 1998). L. major pro-
mastigotes or infected macrophages were harvested by
gentle centrifugation, washed twice in Dulbecco’s phosphate-
buffered saline solution and ﬁxed for 24 h at 37°C in 100 mM
sodium cacodylate buffer with 1% paraformaldehyde and
0.025% glutaraldehyde. Fixed cells were dehydrated step-
wise at increasing ethanol concentrations and embedded in
LR-White with accelerator (London Resin Company, London,
UK). Ultrathin sections were prepared on an Reichert Ultracut
E (Leica, Wetzlar, Germany) and placed on 200-mesh
Pioloform-coated Ni grids.
The sections were then incubated with anti-P46 antiserum
(1:1000) or naive mouse serum (1:1000) for 1 h at 37°C and
then overnight at 4°C. The sections were then treated for 1 h
each with rabbit anti-mouse antibody (1:1000, DAKO) and
with proteinA-gold (10 nm, 1:70, Department. of Cell Biology,
School of Medicine, University of Utrecht, Netherlands).
Staining of subcellular structures was performed in 1% UO2
in water and Pb citrate (Reynolds, 1963). Electron micro-
graphs were taken on a Tecnai Spirit TEM (FEI, Eindhoven,
Netherlands).
Animal care and experimentation were performed in accor-
dance with the German Federal Animal Protection Laws, in
particular §§4, 7 and 10a, in the animal facility of the Bern-
hard Nocht Institute for Tropical Medicine (Hamburg,
Germany).
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Signiﬁcance was assessed by U-test (Mann and Whitney,
1947). For macrophage infection rates, the paired Student’s
t-test was applied to account for different macrophage cell
preparations. All statistical analyses were performed using
the Prism Software (GraphPad). Sequence analysis was per-
formed by a commercial provider (AGOWA, Berlin). We used
the MacVector™ suite software (Version 10.6) for in silico
sequence analysis. BLAST searches were performed at stan-
dard settings, using the GeneDB website (http://tritrypdb.org/
tritrypdb/). Open reading frames were identiﬁed both by
on-site analysis, using MacVector™, and by mining of the L.
major and L. infantum Genome Databases.
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